Study on the medication management in care transitions led by pharmacists in the United States and its implications
- VernacularTitle:美国药师主导的医疗过渡期药物管理模式研究及启示
- Author:
Xia LIU
1
;
Qiuya YANG
1
;
Mian ZHANG
2
Author Information
1. Dept. of Pharmacy，Taikang Shenyuan Rehabilitation Hospital of Shanghai，Shanghai 201620，China
2. Dept. of Internal Medicine，Taikang Shenyuan Rehabilitation Hospital of Shanghai，Shanghai 201620，China
- Publication Type:Journal Article
- Keywords:
transitions of care;
medication management;
clinical pharmacist;
pharmaceutical care
- From:
China Pharmacy
2026;37(1):11-16
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To provide references and suggestions for the establishment of medication management in care transitions in China. METHODS This study systematically reviewed the medication management in care transitions led by pharmacists in the United States， summarized the clinical practice evidence of its service system， personnel configuration， development bottlenecks and effect benefits， and explored the suggestions for optimizing the work in China. RESULTS & CONCLUSIONS The United States medication management in care transitions is characterized by standardized workflows and precision interventions. It focuses on the treatment continuity period when patients transition across institutions and stages， establishing a pharmacist-led， multidisciplinary collaborative monitoring system. Empirical studies confirm its effectiveness in reducing medication errors， lowering healthcare costs， and improving patient satisfaction. The United States model has achieved professionalization and standardization. Adapting its successful experiences as well as combining our local situation can establish a pharmacist-led medication management framework in care transitions through four key dimensions： role definition， training mechanisms， standardized protocols， and evaluation metrics， and improve the further development of pharmaceutical care services.
